Streetbeat News

Price Targets

PXD

Stifel has maintained its Buy rating for Pioneer Natural Resources (NYSE:PXD) and lowered its price target from $290.00 to $273.00. Shares of PXD are trading up 1.62% at $212.33 per share.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 5:02 pm

TRIP

DA Davidson maintains its Buy rating for TripAdvisor (NASDAQ:TRIP) but lowers its price target from $28.00 to $25.00. TripAdvisor shares are trading up 0.25% at $15.92, and a move to $25.00 would represent a 57.04% increase.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 5:01 pm

EIX

Edison Intl (NYSE:EIX) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, 4 indifferent, 5 somewhat bearish, and 2 bearish ratings. The average 12-month price target for EIX is $66.54, up 4.12% from the previous average of $63.91.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 5:00 pm

DE

Wells Fargo has maintained its Overweight rating for Deere (NYSE:DE) but lowered its price target from $510 to $490. Deere's shares are currently trading down 1.55% at $357.91, and a move to $490 would represent a 36.91% increase.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 5:00 pm

BHG

Morgan Stanley has retracted its price target headline on BHG.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:52 pm

AZUL

Bank of America Securities upgraded Azul's stock from Underperform to Neutral and raised its price target from $6.9 to $11, resulting in the shares trading higher.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:45 pm

BAC

A whale has taken a bearish stance on Bank of America (NYSE:BAC), with 53% of detected trades having bearish expectations. Whales have been targeting a price range of $21.0 to $32.0 for BAC over the last 3 months. Evercore ISI Group maintains an Outperform rating with a price target of $35.

Portfolio Pulse from Benzinga Insights

May 22, 2023 | 3:32 pm

CTLT

Morgan Stanley analyst Tejas Savant maintains an Overweight rating on Catalent (NYSE:CTLT) but lowers the price target from $85 to $50.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:18 pm

RNA

Avidity Biosciences' stock has been upgraded from In-Line to Outperform by Evercore ISI Group, with a new price target of $20.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:17 pm

TBI

TrueBlue shares are trading higher after BMO Capital upgraded the stock from Market Perform to Outperform and raised its price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 3:16 pm